ATIM-43. PLASMA EXTRACELLULAR VESICLE MIRNA SIGNATURES IN GBM PATIENTS RECEIVING AN EXPERIMENTAL IMMUNOTHERAPY

MLA

Luz Cumba-Garcia, et al. Atim-43. Plasma Extracellular Vesicle Mirna Signatures in Gbm Patients Receiving an Experimental Immunotherapy. Nov. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....32f60bb2fc82f2a4ddbb722ca8210d07&authtype=sso&custid=ns315887.

APA

Luz Cumba-Garcia, Mrunal Dehankar, Ian F. Parney, & Asha Nair. (2019). Atim-43. Plasma Extracellular Vesicle Mirna Signatures in Gbm Patients Receiving an Experimental Immunotherapy.

Chicago

Luz Cumba-Garcia, Mrunal Dehankar, Ian F. Parney, and Asha Nair. 2019. “Atim-43. Plasma Extracellular Vesicle Mirna Signatures in Gbm Patients Receiving an Experimental Immunotherapy,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....32f60bb2fc82f2a4ddbb722ca8210d07&authtype=sso&custid=ns315887.